Performance of a deep learning-based application for the diagnosis of basal cell carcinoma in Indian patients as compared to dermatologists and nondermatologists

A systematic review and meta-analysis of artificial intelligence versus clinicians for skin cancer diagnosis

Scientific research of artificial intelligence (AI) in dermatology has increased exponentially. The objective of this study was to perform a systematic review and meta-analysis to evaluate the performance of AI algorithms for skin cancer classification in comparison to clinicians with different levels of expertise. Based on PRISMA guidelines, 3 electronic databases (PubMed, Embase, and Cochrane Library) were screened for relevant articles up to August 2022. The quality of the studies was assessed using QUADAS-2. A meta-analysis of sensitivity and specificity was performed for the accuracy of AI and clinicians. Fifty-three studies were included in the systematic review, and 19 met the inclusion criteria for the meta-analysis. Considering all studies and all subgroups of clinicians, we found a sensitivity (Sn) and specificity (Sp) of 87.0% and 77.1% for AI algorithms, respectively, and a Sn of 79.78% and Sp of 73.6% for all clinicians (overall); differences were statistically significant for both Sn and Sp. The difference between AI performance (Sn 92.5%, Sp 66.5%) vs. generalists (Sn 64.6%, Sp 72.8%), was greater, when compared with expert clinicians. Performance between AI algorithms (Sn 86.3%, Sp 78.4%) vs expert dermatologists (Sn 84.2%, Sp 74.4%) was clinically comparable. Limitations of AI algorithms in clinical practice should be considered, and future studies should focus on real-world settings, and towards AI-assistance.

The State of Artificial Intelligence in Skin Cancer Publications

BACKGROUND

Artificial intelligence (AI) in skin cancer is a promising research field to assist physicians and to provide support to patients remotely. Physicians' awareness to new developments in AI research is important to define the best practices and scope of integrating AI-enabled technologies within a clinical setting.

OBJECTIVES

To analyze the characteristics and trends of AI skin cancer publications from dermatology journals.

METHODS

AI skin cancer publications were retrieved in June 2022 from the Web of Science. Publications were screened by title, abstract, and keywords to assess eligibility. Publications were fully reviewed. Publications were divided between nonmelanoma skin cancer (NMSC), melanoma, and skin cancer studies. The primary measured outcome was the number of citations. The secondary measured outcomes were articles' general characteristics and features related to AI.

RESULTS

A total of 168 articles were included: 25 on NMSC, 77 on melanoma, and 66 on skin cancer. The most common types of skin cancers were melanoma (134, 79.8%), basal cell carcinoma (61, 36.3%), and squamous cell carcinoma (45, 26.9%). All articles were published between 2000 and 2022, with 49 (29.2%) of them being published in 2021. Original studies that developed or assessed an algorithm predominantly used supervised learning (66, 97.0%) and deep neural networks (42, 67.7%). The most used imaging modalities were standard dermoscopy (76, 45.2%) and clinical images (39, 23.2%).

CONCLUSIONS

Most publications focused on developing or assessing screening technologies with mainly deep neural network algorithms. This indicates the eminent need for dermatologists to label or annotate images used by novel AI systems.

Does a Previous Segmentation Improve the Automatic Detection of Basal Cell Carcinoma Using Deep Neural Networks?

Basal Cell Carcinoma (BCC) is the most frequent skin cancer and its increasing incidence is producing a high overload in dermatology services. In this sense, it is convenient to aid physicians in detecting it soon. Thus, in this paper, we propose a tool for the detection of BCC to provide a prioritization in the teledermatology consultation. Firstly, we analyze if a previous segmentation of the lesion improves the ulterior classification of the lesion. Secondly, we analyze three deep neural networks and ensemble architectures to distinguish between BCC and nevus, and BCC and other skin lesions. The best segmentation results are obtained with a SegNet deep neural network. A 98% accuracy for distinguishing BCC from nevus and a 95% accuracy classifying BCC vs. all lesions have been obtained. The proposed algorithm outperforms the winner of the challenge ISIC 2019 in almost all the metrics. Finally, we can conclude that when deep neural networks are used to classify, a previous segmentation of the lesion does not improve the classification results. Likewise, the ensemble of different neural network configurations improves the classification performance compared with individual neural network classifiers. Regarding the segmentation step, supervised deep learning-based methods outperform unsupervised ones.